313 related articles for article (PubMed ID: 23797621)
1. Cytokine pathways and interactions in alopecia areata.
Giordano CN; Sinha AA
Eur J Dermatol; 2013; 23(3):308-18. PubMed ID: 23797621
[TBL] [Abstract][Full Text] [Related]
2. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata.
Ito T; Tokura Y
Exp Dermatol; 2014 Nov; 23(11):787-91. PubMed ID: 25040075
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
4. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata.
Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X
Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328
[TBL] [Abstract][Full Text] [Related]
5. The autoimmune basis of alopecia areata: a comprehensive review.
Islam N; Leung PS; Huntley AC; Gershwin ME
Autoimmun Rev; 2015 Feb; 14(2):81-9. PubMed ID: 25315746
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
7. The potential role of cytokines and T cells in alopecia areata.
Hoffmann R
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):235-8. PubMed ID: 10674373
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata in patients with inflammatory bowel disease: an overview.
Sobolewska-Włodarczyk A; Włodarczyk M; Fichna J; Wiśniewska-Jarosińska M
Folia Med Cracov; 2016; 56(1):5-12. PubMed ID: 27513834
[TBL] [Abstract][Full Text] [Related]
9. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
Paus R; Slominski A; Czarnetzki BM
Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of alopecia areata: modern principles and perspectives].
Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
13. The role of lymphocytes in the development and treatment of alopecia areata.
Guo H; Cheng Y; Shapiro J; McElwee K
Expert Rev Clin Immunol; 2015; 11(12):1335-51. PubMed ID: 26548356
[TBL] [Abstract][Full Text] [Related]
14. Etiopathogenesis of alopecia areata: Why do our patients get it?
Wang E; McElwee KJ
Dermatol Ther; 2011; 24(3):337-47. PubMed ID: 21689243
[TBL] [Abstract][Full Text] [Related]
15. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
17. A novel therapeutic paradigm for patients with extensive alopecia areata.
Renert-Yuval Y; Guttman-Yassky E
Expert Opin Biol Ther; 2016 Aug; 16(8):1005-14. PubMed ID: 27164008
[TBL] [Abstract][Full Text] [Related]
18. Treatment of alopecia areata: "What is new on the horizon?".
Hordinsky MK
Dermatol Ther; 2011; 24(3):364-8. PubMed ID: 21689246
[TBL] [Abstract][Full Text] [Related]
19. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
[TBL] [Abstract][Full Text] [Related]
20. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
Trüeb RM; Dias MFRG
Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
